Meeting
2021 ASCO Annual Meeting
Comparison of treatment effect and long-term outcomes for pediatric and adult Ewing sarcoma patients in British Columbia, Canada.
Authors
Omar Hajjaj
BCCA Vancouver, Vancouver, BC, Canada
Omar Hajjaj , Lauren Corke , Caron Strahlendorf , Christine E. Simmons
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Bone Tumors
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 11531)
DOI
10.1200/JCO.2021.39.15_suppl.11531
Abstract #
11531
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2019 ASCO Annual Meeting
Outcomes of extra-skeletal versus skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
First Author: Samer Salah
Poster
2016 ASCO Annual Meeting
Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
First Author: Melanie Ann Chihak
Poster
2022 ASCO Annual Meeting
Risk-adapted local therapy and intensive chemotherapy in patients with high-risk rhabdomyosarcoma.
First Author: Michael W. Bishop